PFAM Search:   
       by Pfam accession/ID, keyword
QuickSearch:   
by PDB,NDB,UniProt,PROSITE Code or Search Term(s)  

Full view: branches of nodes matching the query are shown completely (Compact view)

(use 'Shift Left-Click' to collapse/expand all levels downwards; use 'Control Left-Click' to collapse/expand all levels upwards)
 
(-)
Clan: Insulin (93)
(-)
Family: Ins_beta (1)
(-)
Caenorhabditis elegans (1)
2KJIA:3-50A DIVERGENT INS PROTEIN IN C. ELEGANS STRUCTURALLY RESEMBLE INSULIN AND ACTIVATES THE HUMAN INSULIN RECEPTOR
(-)
Family: Insulin (92)
(-)
Bos taurus (Bovine) (2)
1PIDD:4-25; D:4-25; D:4-25; D:4-25BOVINE DESPENTAPEPTIDE INSULIN
2ZP6D:4-30; D:4-30; D:4-30; D:4-30CRYSTAL STRUCTURE OF BOVINE INSULIN (HEXAMERIC FORM)
(-)
Drosophila melanogaster (Fruit fly) (1)
2WFVB:3-23; B:3-23CRYSTAL STRUCTURE OF DILP5 VARIANT C4
(-)
Homo sapiens (Human) (79)
1PMXA:3-61INSULIN-LIKE GROWTH FACTOR-I BOUND TO A PHAGE-DERIVED PEPTIDE
1TGRB:3-51; B:3-51CRYSTAL STRUCTURE OF MINI-IGF-1(2)
1WQJI:3-61STRUCTURAL BASIS FOR THE REGULATION OF INSULIN-LIKE GROWTH FACTORS (IGFS) BY IGF BINDING PROTEINS (IGFBPS)
3LRIA:16-74SOLUTION STRUCTURE AND BACKBONE DYNAMICS OF LONG-[ARG(3) ]INSULIN-LIKE GROWTH FACTOR-I
2V5PD:40-60; D:40-60; D:40-60; D:40-60COMPLEX STRUCTURE OF HUMAN IGF2R DOMAINS 11-13 BOUND TO IGF-II
3KR3D:30-60; D:30-60CRYSTAL STRUCTURE OF IGF-II ANTIBODY COMPLEX
2K6UB:31-49; B:31-49THE SOLUTION STRUCTURE OF A CONFORMATIONALLY RESTRICTED FULLY ACTIVE DERIVATIVE OF THE HUMAN RELAXIN-LIKE FACTOR (RLF)
2K1VA:5-24; B:7-27R3/I5 RELAXIN CHIMERA
2KBCB:4-24; B:4-24SOLUTION STRUCTURE OF HUMAN INSULIN-LIKE PEPTIDE 5 (INSL5)
1JCAD:4-30; D:4-30; D:4-30; D:4-30NON-STANDARD DESIGN OF UNSTABLE INSULIN ANALOGUES WITH ENHANCED ACTIVITY
1JCOB:4-26; B:4-26SOLUTION STRUCTURE OF THE MONOMERIC [THR(B27)->PRO,PRO(B28)->THR] INSULIN MUTANT (PT INSULIN)
1KMFB:4-27; B:4-27NMR STRUCTURE OF HUMAN INSULIN MUTANT ILE-A2-ALLO-ILE, HIS-B10-ASP, PRO-B28-LYS, LYS-B29-PRO, 15 STRUCTURES
1LKQB:4-27; B:4-27NMR STRUCTURE OF HUMAN INSULIN MUTANT ILE-A2-GLY, VAL-A3-GLY, HIS-B10-ASP, PRO-B28-LYS, LYS-B29-PRO, 20 STRUCTURES
1LPHD:4-27; D:4-27; D:4-27; D:4-27LYS(B28)PRO(B29)-HUMAN INSULIN
1MHIB:4-30; B:4-30THREE-DIMENSIONAL SOLUTION STRUCTURE OF AN INSULIN DIMER. A STUDY OF THE B9(ASP) MUTANT OF HUMAN INSULIN USING NUCLEAR MAGNETIC RESONANCE DISTANCE GEOMETRY AND RESTRAINED MOLECULAR DYNAMICS
1MHJB:4-23; B:4-23SOLUTION STRUCTURE OF THE SUPERACTIVE MONOMERIC DES-[PHE(B25)] HUMAN INSULIN MUTANT. ELUCIDATION OF THE STRUCTURAL BASIS FOR THE MONOMERIZATION OF THE DES-[PHE(B25)] INSULIN AND THE DIMERIZATION OF NATIVE INSULIN
1MSOD:4-30; D:4-30; D:4-30; D:4-30T6 HUMAN INSULIN AT 1.0 A RESOLUTION
1OS3D:4-28; D:4-28; D:4-28; D:4-28DEHYDRATED T6 HUMAN INSULIN AT 100 K
1OS4L:4-28; L:4-28; L:4-28; L:4-28; L:4-28; L:4-28; L:4-28; L:4-28; L:4-28; L:4-28; L:4-28; L:4-28DEHYDRATED T6 HUMAN INSULIN AT 295 K
1Q4VD:4-30; D:4-30; D:4-30; D:4-30CRYSTAL STRUCTURE OF ALLO-ILEA2-INSULIN, AN INACTIVE CHIRAL ANALOGUE: IMPLICATIONS FOR THE MECHANISM OF RECEPTOR
1QIYL:4-30; L:4-30; L:4-30; L:4-30; L:4-30; L:4-30; L:4-30; L:4-30; L:4-30; L:4-30; L:4-30; L:4-30HUMAN INSULIN HEXAMERS WITH CHAIN B HIS MUTATED TO TYR COMPLEXED WITH PHENOL
1QIZL:4-30; L:4-30; L:4-30; L:4-30; L:4-30; L:4-30; L:4-30; L:4-30; L:4-30; L:4-30; L:4-30; L:4-30HUMAN INSULIN HEXAMERS WITH CHAIN B HIS MUTATED TO TYR COMPLEXED WITH RESORCINOL
1QJ0D:4-30; D:4-30; D:4-30; D:4-30HUMAN INSULIN HEXAMERS WITH CHAIN B HIS MUTATED TO TYR
1RWED:4-30; D:4-30; D:4-30; D:4-30ENHANCING THE ACTIVITY OF INSULIN AT RECEPTOR EDGE: CRYSTAL STRUCTURE AND PHOTO-CROSS-LINKING OF A8 ANALOGUES
1SF1B:4-30; B:4-30NMR STRUCTURE OF HUMAN INSULIN UNDER AMYLOIDOGENIC CONDITION, 15 STRUCTURES
1SJTB:4-27; B:4-27MINI-PROINSULIN, TWO CHAIN INSULIN ANALOG MUTANT: DES B30, HIS(B 10)ASP, PRO(B 28)ASP, NMR, 20 STRUCTURES
1SJUA:4-49MINI-PROINSULIN, SINGLE CHAIN INSULIN ANALOG MUTANT: DES B30, HIS(B 10)ASP, PRO(B 28)ASP AND PEPTIDE BOND BETWEEN LYS B 29 AND GLY A 1, NMR, 20 STRUCTURES
1T0CA:1-31SOLUTION STRUCTURE OF HUMAN PROINSULIN C-PEPTIDE
1T1KB:4-27; B:4-27NMR STRUCTURE OF HUMAN INSULIN MUTANT HIS-B10-ASP, VAL-B12-ALA, PRO-B28-LYS, LYS-B29-PRO, 15 STRUCTURES
1T1PB:4-27; B:4-27NMR STRUCTURE OF HUMAN INSULIN MUTANT HIS-B10-ASP, VAL-B12-THR, PRO-B28-LYS, LYS-B29-PRO, 15 STRUCTURES
1TRZD:4-30; D:4-30; D:4-30; D:4-30CRYSTALLOGRAPHIC EVIDENCE FOR DUAL COORDINATION AROUND ZINC IN THE T3R3 HUMAN INSULIN HEXAMER
1TYLD:4-30; D:4-30; D:4-30; D:4-30THE STRUCTURE OF A COMPLEX OF HEXAMERIC INSULIN AND 4'-HYDROXYACETANILIDE
1TYMD:4-30; D:4-30; D:4-30; D:4-30THE STRUCTURE OF A COMPLEX OF HEXAMERIC INSULIN AND 4'-HYDROXYACETANILIDE
1UZ9B:4-28; B:4-28CRYSTALLOGRAPHIC AND SOLUTION STUDIES OF N-LITHOCHOLYL INSULIN: A NEW GENERATION OF PROLONGED-ACTING INSULINS.
1VKTB:4-27; B:4-27HUMAN INSULIN TWO DISULFIDE MODEL, NMR, 10 STRUCTURES
1W8PL:4-28; L:4-28; L:4-28; L:4-28; L:4-28; L:4-28; L:4-28; L:4-28; L:4-28; L:4-28; L:4-28; L:4-28STRUCTURAL PROPERTIES OF THE B25TYR-NME-B26PHE INSULIN MUTANT.
1XDAH:4-29; H:4-29; H:4-29; H:4-29; H:4-29; H:4-29; H:4-29; H:4-29STRUCTURE OF INSULIN
1XGLB:4-30; B:4-30HUMAN INSULIN DISULFIDE ISOMER, NMR, 10 STRUCTURES
1XW7D:4-30; D:4-30; D:4-30; D:4-30DIABETES-ASSOCIATED MUTATIONS IN HUMAN INSULIN: CRYSTAL STRUCTURE AND PHOTO-CROSS-LINKING STUDIES OF A-CHAIN VARIANT INSULIN WAKAYAMA
1ZEGD:4-30; D:4-30; D:4-30; D:4-30STRUCTURE OF B28 ASP INSULIN IN COMPLEX WITH PHENOL
1ZEHD:4-30; D:4-30; D:4-30; D:4-30STRUCTURE OF INSULIN
1ZNJL:4-30; L:4-30; L:4-30; L:4-30; L:4-30; L:4-30; L:4-30; L:4-30; L:4-30; L:4-30; L:4-30; L:4-30INSULIN, MONOCLINIC CRYSTAL FORM
2JMNB:4-27; B:4-27NMR STRUCTURE OF HUMAN INSULIN MUTANT HIS-B10-ASP, PRO-B28-LYS, LYS-B29-PRO, 20 STRUCTURES
2JUMB:4-27; B:4-27THRA3-DKP-INSULIN
2JUUB:4-27; B:4-27ALLO-THRA3 DKP-INSULIN
2JUVB:4-27; B:4-27ABAA3-DKP-INSULIN
2JV1B:4-30; B:4-30NMR STRUCTURE OF HUMAN INSULIN MONOMER IN 35% CD3CN ZINC FREE, 50 STRUCTURES
2K91B:4-27; B:4-27ENHANCING THE ACTIVITY OF INSULIN BY STEREOSPECIFIC UNFOLDING
2K9RB:4-27; B:4-27ENHANCING THE ACTIVITY OF INSULIN BY STEREOSPECIFIC UNFOLDING
2KJJB:4-27; B:4-27DYNAMICS OF INSULIN PROBED BY 1H-NMR AMIDE PROTON EXCHANGE ANOMALOUS FLEXIBILITY OF THE RECEPTOR-BINDING SURFACE
2KQPA:4-85NMR STRUCTURE OF PROINSULIN
2KQQB:4-27; B:4-27NMR STRUCTURE OF HUMAN INSULIN MUTANT GLY-B8-D-ALA, HIS-B10-ASP, PRO-B28-LYS, LYS-B29-PRO, 20 STRUCTURES
2KXKB:4-30; B:4-30HUMAN INSULIN MUTANT A22GLY-B31LYS-B32ARG
2OLYL:4-28; L:4-28; L:4-28; L:4-28; L:4-28; L:4-28; L:4-28; L:4-28; L:4-28; L:4-28; L:4-28; L:4-28STRUCTURE OF HUMAN INSULIN IN PRESENCE OF UREA AT PH 7.0
2OLZL:4-28; L:4-28; L:4-28; L:4-28; L:4-28; L:4-28; L:4-28; L:4-28; L:4-28; L:4-28; L:4-28; L:4-28STRUCTURE OF HUMAN INSULIN IN PRESENCE OF THIOCYANATE AT PH 7.0
2OM0Y:4-29; Y:4-29; Y:4-29; Y:4-29; Y:4-29; Y:4-29; Y:4-29; Y:4-29; Y:4-29; Y:4-29; Y:4-29; Y:4-29; Y:4-29; Y:4-29; Y:4-29; Y:4-29; Y:4-29; Y:4-29; Y:4-29; Y:4-29; Y:4-29; Y:4-29; Y:4-29; Y:4-29; Y:4-29; Y:4-29; Y:4-29; Y:4-29; Y:4-29; Y:4-29; Y:4-29; Y:4-29; Y:4-29; Y:4-29; Y:4-29; Y:4-29STRUCTURE OF HUMAN INSULIN IN PRESENCE OF UREA AT PH 6.5
2OM1Y:4-29; Y:4-29; Y:4-29; Y:4-29; Y:4-29; Y:4-29; Y:4-29; Y:4-29; Y:4-29; Y:4-29; Y:4-29; Y:4-29; Y:4-29; Y:4-29; Y:4-29; Y:4-29; Y:4-29; Y:4-29; Y:4-29; Y:4-29; Y:4-29; Y:4-29; Y:4-29; Y:4-29; Y:4-29; Y:4-29; Y:4-29; Y:4-29; Y:4-29; Y:4-29; Y:4-29; Y:4-29; Y:4-29; Y:4-29; Y:4-29; Y:4-29STRUCTURE OF HUMAN INSULIN IN PRESENCE OF THIOCYANATE AT PH 6.5
2OMGF:4-28; F:4-28; F:4-28; F:4-28; F:4-28; F:4-28STRUCTURE OF HUMAN INSULIN COCRYSTALLIZED WITH PROTAMINE AND UREA
2OMIL:4-28; L:4-28; L:4-28; L:4-28; L:4-28; L:4-28; L:4-28; L:4-28; L:4-28; L:4-28; L:4-28; L:4-28STRUCTURE OF HUMAN INSULIN COCRYSTALLIZED WITH PROTAMINE
2QIUD:4-30; D:4-30; D:4-30; D:4-30STRUCTURE OF HUMAN ARG-INSULIN
2R34D:4-29; D:4-29; D:4-29; D:4-29CRYSTAL STRUCTURE OF MN HUMAN ARG-INSULIN
2R36D:4-30; D:4-30; D:4-30; D:4-30CRYSTAL STRUCTURE OF NI HUMAN ARG-INSULIN
2RN5B:4-30; B:4-30HUMAL INSULIN MUTANT B31LYS-B32ARG
2VJZD:4-28; D:4-28; D:4-28; D:4-28CRYSTAL STRUCTURE FORM ULTALENTE INSULIN MICROCRYSTALS
2VK0D:4-29; D:4-29; D:4-29; D:4-29CRYSTAL STRUCTURE FORM ULTALENTE INSULIN MICROCRYSTALS
2W44F:4-29; F:4-29; F:4-29; F:4-29; F:4-29; F:4-29STRUCTURE DELTAA1-A4 INSULIN
2WBYF:4-19; F:4-19; F:4-19; F:4-19CRYSTAL STRUCTURE OF HUMAN INSULIN-DEGRADING ENZYME IN COMPLEX WITH INSULIN
2WC0F:4-20; F:4-20; F:4-20; F:4-20CRYSTAL STRUCTURE OF HUMAN INSULIN DEGRADING ENZYME IN COMPLEX WITH IODINATED INSULIN
2WRUB:4-25; B:4-25SEMI-SYNTHETIC HIGHLY ACTIVE ANALOGUE OF HUMAN INSULIN NMEALAB26-DTI-NH2
2WRVB:4-25; B:4-25SEMI-SYNTHETIC HIGHLY ACTIVE ANALOGUE OF HUMAN INSULIN NMEHISB26-DTI-NH2
2WRWB:4-25; B:4-25SEMI-SYNTHETIC HIGHLY ACTIVE ANALOGUE OF HUMAN INSULIN D-PROB26-DTI-NH2
2WRXD:4-28; D:4-28; D:4-28; D:4-28SEMI-SYNTHETIC ANALOGUE OF HUMAN INSULIN NMEALAB26-INSULIN AT PH 3.0
2WS0B:4-27; B:4-27SEMI-SYNTHETIC ANALOGUE OF HUMAN INSULIN NMEALAB26-INSULIN AT PH 7.5
2WS4B:4-25; B:4-25SEMI-SYNTHETIC ANALOGUE OF HUMAN INSULIN PROB26-DTI IN MONOMER FORM
2WS6L:4-27; L:4-27; L:4-27; L:4-27; L:4-27; L:4-27; L:4-27; L:4-27; L:4-27; L:4-27; L:4-27; L:4-27SEMI-SYNTHETIC ANALOGUE OF HUMAN INSULIN NMETYRB26-INSULIN IN HEXAMER FORM
2WS7L:4-22; L:4-22; L:4-22; L:4-22; L:4-22; L:4-22; L:4-22; L:4-22; L:4-22; L:4-22; L:4-22; L:4-22SEMI-SYNTHETIC ANALOGUE OF HUMAN INSULIN PROB26-DTI
3JSDD:4-30; D:4-30; D:4-30; D:4-30INSULIN'S BIOSYNTHESIS AND ACTIVITY HAVE OPPOSING STRUCTURAL REQUIREMENTS: A NEW FACTOR IN NEONATAL DIABETES MELLITUS
3KQ6D:4-30; D:4-30; D:4-30; D:4-30ENHANCING THE THERAPEUTIC PROPERTIES OF A PROTEIN BY A DESIGNED ZINC-BINDING SITE, STRUCTURAL PRINCIPLES OF A NOVEL LONG-ACTING INSULIN ANALOG
3Q6ED:4-30; D:4-30; D:4-30; D:4-30HUMAN INSULIN IN COMPLEX WITH CUCURBIT[7]URIL
(-)
Sus scrofa (Pig) (10)
1M5AD:4-30; D:4-30; D:4-30; D:4-30CRYSTAL STRUCTURE OF 2-CO(2+)-INSULIN AT 1.2A RESOLUTION
1MPJD:4-30; D:4-30; D:4-30; D:4-30X-RAY CRYSTALLOGRAPHIC STUDIES ON HEXAMERIC INSULINS IN THE PRESENCE OF HELIX-STABILIZING AGENTS, THIOCYANATE, METHYLPARABEN AND PHENOL
1SDBB:4-25; B:4-25PORCINE DESB1-2 DESPENTAPEPTIDE(B26-B30) INSULIN
1WAVL:4-30; L:4-30; L:4-30; L:4-30; L:4-30; L:4-30; L:4-30; L:4-30; L:4-30; L:4-30; L:4-30; L:4-30CRYSTAL STRUCTURE OF FORM B MONOCLINIC CRYSTAL OF INSULIN
1ZEIF:4-52; F:4-52; F:4-52; F:4-52; F:4-52; F:4-52CROSS-LINKED B28 ASP INSULIN
1ZNID:4-30; D:4-30; D:4-30; D:4-30INSULIN
2TCID:4-30; D:4-30; D:4-30; D:4-30X-RAY CRYSTALLOGRAPHIC STUDIES ON HEXAMERIC INSULINS IN THE PRESENCE OF HELIX-STABILIZING AGENTS, THIOCYANATE, METHYLPARABEN AND PHENOL
2ZPPB:4-30; B:4-30NEUTRON CRYSTAL STRUCTURE OF CUBIC INSULIN AT PD9
3MTHD:4-30; D:4-30; D:4-30; D:4-30X-RAY CRYSTALLOGRAPHIC STUDIES ON HEXAMERIC INSULINS IN THE PRESENCE OF HELIX-STABILIZING AGENTS, THIOCYANATE, METHYLPARABEN AND PHENOL
3RTOD:4-30; D:4-30; D:4-30; D:4-30ACOUSTICALLY MOUNTED PORCINE INSULIN MICROCRYSTALS YIELD AN X-RAY SAD STRUCTURE